S&P 500   3,334.93 (-1.14%)
DOW   28,980.70 (-0.82%)
QQQ   229.89 (-2.09%)
AAPL   312.08 (-2.57%)
FB   210.14 (-2.07%)
MSFT   178.07 (-3.44%)
GOOGL   1,482.64 (-2.27%)
AMZN   2,093.61 (-2.76%)
CGC   21.96 (-1.61%)
NVDA   292.86 (-5.13%)
BABA   212.22 (-2.67%)
GE   12.31 (-1.76%)
TSLA   896.43 (-0.33%)
AMD   53.39 (-6.78%)
T   38.48 (-0.34%)
ACB   1.66 (-1.19%)
DIS   138.82 (-1.10%)
S&P 500   3,334.93 (-1.14%)
DOW   28,980.70 (-0.82%)
QQQ   229.89 (-2.09%)
AAPL   312.08 (-2.57%)
FB   210.14 (-2.07%)
MSFT   178.07 (-3.44%)
GOOGL   1,482.64 (-2.27%)
AMZN   2,093.61 (-2.76%)
CGC   21.96 (-1.61%)
NVDA   292.86 (-5.13%)
BABA   212.22 (-2.67%)
GE   12.31 (-1.76%)
TSLA   896.43 (-0.33%)
AMD   53.39 (-6.78%)
T   38.48 (-0.34%)
ACB   1.66 (-1.19%)
DIS   138.82 (-1.10%)
S&P 500   3,334.93 (-1.14%)
DOW   28,980.70 (-0.82%)
QQQ   229.89 (-2.09%)
AAPL   312.08 (-2.57%)
FB   210.14 (-2.07%)
MSFT   178.07 (-3.44%)
GOOGL   1,482.64 (-2.27%)
AMZN   2,093.61 (-2.76%)
CGC   21.96 (-1.61%)
NVDA   292.86 (-5.13%)
BABA   212.22 (-2.67%)
GE   12.31 (-1.76%)
TSLA   896.43 (-0.33%)
AMD   53.39 (-6.78%)
T   38.48 (-0.34%)
ACB   1.66 (-1.19%)
DIS   138.82 (-1.10%)
S&P 500   3,334.93 (-1.14%)
DOW   28,980.70 (-0.82%)
QQQ   229.89 (-2.09%)
AAPL   312.08 (-2.57%)
FB   210.14 (-2.07%)
MSFT   178.07 (-3.44%)
GOOGL   1,482.64 (-2.27%)
AMZN   2,093.61 (-2.76%)
CGC   21.96 (-1.61%)
NVDA   292.86 (-5.13%)
BABA   212.22 (-2.67%)
GE   12.31 (-1.76%)
TSLA   896.43 (-0.33%)
AMD   53.39 (-6.78%)
T   38.48 (-0.34%)
ACB   1.66 (-1.19%)
DIS   138.82 (-1.10%)
Log in

NASDAQ:SCPH - Scpharmaceuticals Stock Price, Forecast & News

$10.50
+0.05 (+0.48 %)
(As of 02/21/2020 02:38 PM ET)
Today's Range
$10.25
Now: $10.50
$10.59
50-Day Range
$5.40
MA: $6.47
$10.45
52-Week Range
$2.44
Now: $10.50
$10.93
Volume14,060 shs
Average Volume102,672 shs
Market Capitalization$195.62 million
P/E RatioN/A
Dividend YieldN/A
Beta0.79
scPharmaceuticals Inc, a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix that consists of proprietary subcutaneous formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients outside of the acute care setting. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SCPH
CUSIPN/A
Phone617-517-0730

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$4.24 per share

Profitability

Net Income$-29,440,000.00

Miscellaneous

Employees21
Market Cap$195.62 million
Next Earnings Date3/19/2020 (Estimated)
OptionableNot Optionable

Receive SCPH News and Ratings via Email

Sign-up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter.


Scpharmaceuticals (NASDAQ:SCPH) Frequently Asked Questions

What is Scpharmaceuticals' stock symbol?

Scpharmaceuticals trades on the NASDAQ under the ticker symbol "SCPH."

How were Scpharmaceuticals' earnings last quarter?

Scpharmaceuticals Inc (NASDAQ:SCPH) released its earnings results on Tuesday, November, 12th. The company reported ($0.33) EPS for the quarter, topping the consensus estimate of ($0.45) by $0.12. View Scpharmaceuticals' Earnings History.

When is Scpharmaceuticals' next earnings date?

Scpharmaceuticals is scheduled to release their next quarterly earnings announcement on Thursday, March 19th 2020. View Earnings Estimates for Scpharmaceuticals.

What price target have analysts set for SCPH?

1 brokers have issued 1-year price objectives for Scpharmaceuticals' stock. Their forecasts range from $13.00 to $13.00. On average, they anticipate Scpharmaceuticals' share price to reach $13.00 in the next twelve months. This suggests a possible upside of 23.8% from the stock's current price. View Analyst Price Targets for Scpharmaceuticals.

What is the consensus analysts' recommendation for Scpharmaceuticals?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Scpharmaceuticals in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Scpharmaceuticals.

Has Scpharmaceuticals been receiving favorable news coverage?

News stories about SCPH stock have trended extremely negative this week, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Scpharmaceuticals earned a news sentiment score of -4.2 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Scpharmaceuticals.

Are investors shorting Scpharmaceuticals?

Scpharmaceuticals saw a increase in short interest in January. As of January 31st, there was short interest totalling 20,200 shares, an increase of 43.3% from the January 15th total of 14,100 shares. Based on an average trading volume of 45,900 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.2% of the company's shares are short sold. View Scpharmaceuticals' Current Options Chain.

Who are some of Scpharmaceuticals' key competitors?

What other stocks do shareholders of Scpharmaceuticals own?

Who are Scpharmaceuticals' key executives?

Scpharmaceuticals' management team includes the folowing people:
  • Mr. John H. Tucker, Pres, CEO, CFO & Director (Age 56)
  • Dr. Pieter Muntendam, Consultant (Age 61)
  • Ms. Rachael Nokes, Principal Accounting Officer
  • Katherine Taudvin, Director of Corp. Devel. & Investor Relations
  • Dr. John Mohr Pharm.D., Sr. VP of Clinical Devel. & Medical Affairs

When did Scpharmaceuticals IPO?

(SCPH) raised $96 million in an IPO on Friday, November 17th 2017. The company issued 6,400,000 shares at a price of $14.00-$16.00 per share. Jefferies, Leerink Partners and BMO Capital Markets served as the underwriters for the IPO.

Who are Scpharmaceuticals' major shareholders?

Scpharmaceuticals' stock is owned by a variety of of retail and institutional investors. Top institutional investors include 5AM Venture Management LLC (17.46%), Renaissance Technologies LLC (0.88%), Alambic Investment Management L.P. (0.27%), Geode Capital Management LLC (0.17%) and Jacobs Levy Equity Management Inc. (0.10%). Company insiders that own Scpharmaceuticals stock include John H Tucker, Ra Capital Healthcare Fund Lp and Ra Capital Management, LP. View Institutional Ownership Trends for Scpharmaceuticals.

Which institutional investors are selling Scpharmaceuticals stock?

SCPH stock was sold by a variety of institutional investors in the last quarter, including Alambic Investment Management L.P. and Geode Capital Management LLC. View Insider Buying and Selling for Scpharmaceuticals.

Which institutional investors are buying Scpharmaceuticals stock?

SCPH stock was acquired by a variety of institutional investors in the last quarter, including 5AM Venture Management LLC, Renaissance Technologies LLC and Jacobs Levy Equity Management Inc.. Company insiders that have bought Scpharmaceuticals stock in the last two years include John H Tucker, Ra Capital Healthcare Fund Lp and Ra Capital Management, LP. View Insider Buying and Selling for Scpharmaceuticals.

How do I buy shares of Scpharmaceuticals?

Shares of SCPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Scpharmaceuticals' stock price today?

One share of SCPH stock can currently be purchased for approximately $10.50.

How big of a company is Scpharmaceuticals?

Scpharmaceuticals has a market capitalization of $195.62 million. The company earns $-29,440,000.00 in net income (profit) each year or ($1.59) on an earnings per share basis. Scpharmaceuticals employs 21 workers across the globe.View Additional Information About Scpharmaceuticals.

What is Scpharmaceuticals' official website?

The official website for Scpharmaceuticals is http://www.scpharma.com/.

How can I contact Scpharmaceuticals?

Scpharmaceuticals' mailing address is 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA, 01830. The company can be reached via phone at 617-517-0730 or via email at [email protected]


MarketBeat Community Rating for Scpharmaceuticals (NASDAQ SCPH)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  134 (Vote Outperform)
Underperform Votes:  136 (Vote Underperform)
Total Votes:  270
MarketBeat's community ratings are surveys of what our community members think about Scpharmaceuticals and other stocks. Vote "Outperform" if you believe SCPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SCPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Featured Article: Dividend

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel